Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Jun 16;162(7):S-594–S-595. doi: 10.1016/S0016-5085(22)61407-0

Su1485: COVID-19 VACCINE-INDUCED ANTIBODY RESPONSES ARE IMPAIRED IN IBD PATIENTS TREATED WITH INFLIXIMAB, USTEKINUMAB OR TOFACITINIB, BUT NOT THIOPURINES OR VEDOLIZUMAB

James L Alexander, Nick Kennedy, Hajir Ibraheim, Sulak Anandabaskaran, Aamir Saifuddin, Rocio Castro Seoane, Zhigang Liu, Rachel Nice, Claire M Bewshea, Andrea D'Mello, Laura E Constable, Gareth-Rhys Jones, Sharmili Balarajah, Francesca Fiorentino, Shaji Sebastian, Peter M Irving, Lucy C Hicks, Horace R Williams, Alexandra J Kent, Miles Parkes, Klaartje Kok, Kamal V Patel, Daniel Altmann, Rosemary Boyton, James Goodhand, Ailsa Hart, Charlie W Lees, Tariq Ahmad, Nick Powell
PMCID: PMC9212464

The content is available as a PDF (1.4 MB).


Articles from Gastroenterology are provided here courtesy of Elsevier

RESOURCES